Clorox Files 8-K with Financial Updates

Ticker: CLX · Form: 8-K · Filed: 2024-08-01T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-K, disclosure

Related Tickers: CLX

TL;DR

CLX dropped its 8-K, check the financials and exhibits.

AI Summary

On August 1, 2024, The Clorox Company filed an 8-K report detailing its financial results and other relevant information. The filing includes information on the company's operations, financial condition, and disclosures under Regulation FD. Specific financial statements and exhibits are also provided as part of this report.

Why It Matters

This filing provides investors with crucial, up-to-date financial information and operational details for The Clorox Company, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) that provides standard disclosures and does not indicate any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for The Clorox Company?

The primary purpose is to report on the Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits as of August 1, 2024.

When was the earliest event reported in this filing?

The earliest event reported is dated August 1, 2024.

In which state is The Clorox Company incorporated?

The Clorox Company is incorporated in Delaware.

What is the principal executive office address for The Clorox Company?

The principal executive offices are located at 1221 Broadway, Oakland, California 94612-1888.

What is the Commission File Number for The Clorox Company?

The Commission File Number for The Clorox Company is 1-07151.

From the Filing

0000021076-24-000027.txt : 20240801 0000021076-24-000027.hdr.sgml : 20240801 20240801161220 ACCESSION NUMBER: 0000021076-24-000027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20240801 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 241166819 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 8-K 1 clx-20240801.htm 8-K clx-20240801 0000021076 False 0000021076 2024-08-01 2024-08-01     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2024 THE CLOROX COMPANY (Exact name of registrant as specified in its charter) __________________ Delaware 1-07151 31-0595760 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation) Identification No.) 1221 Broadway , Oakland , California 94612-1888 (Address of principal executive offices) (Zip code) ( 510 ) 271-7000 (Registrant's telephone number, including area code) Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)     [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock - $1.00 par value CLX New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐     1 Item 2.02 Results of Operations and Financial Condition On August 1, 2024, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2024. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 7.01 Regulation FD Disclosure Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information. The Clorox Company additionally announced in the press release that it has entered into a definitive agreement to divest its Better Health Vitamins, Minerals and Supplements business. Item 9.01 Financial Statements and Exhibits (d) Exhibits

View on Read The Filing